Literature DB >> 19022175

Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules.

Ariele Viacava Follis1, Dalia I Hammoudeh, Huabo Wang, Edward V Prochownik, Steven J Metallo.   

Abstract

The basic-helix-loop-helix-leucine-zipper domains of the c-Myc oncoprotein and its obligate partner Max are intrinsically disordered (ID) monomers that undergo coupled folding and binding upon heterodimerization. We have identified the binding sites and determined the structural means by which two unrelated small molecules, 10058-F4 and 10074-G5, bind c-Myc and stabilize the ID monomer over the highly ordered c-Myc-Max heterodimer. In solution, the molecules bind to distinct regions of c-Myc and thus limit its ability to interact with Max and assume a more rigid and defined conformation. The identification of multiple, specific binding sites on an ID domain suggests that small molecules may provide a general means for manipulating the structure and function of ID proteins, such as c-Myc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022175     DOI: 10.1016/j.chembiol.2008.09.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  70 in total

1.  Stochastic simulation of structural properties of natively unfolded and denatured proteins.

Authors:  David Curcó; Catherine Michaux; Guillaume Roussel; Emmanuel Tinti; Eric A Perpète; Carlos Alemán
Journal:  J Mol Model       Date:  2012-05-29       Impact factor: 1.810

Review 2.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

3.  Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function.

Authors:  Hao Jiang; Kristen E Bower; Albert E Beuscher; Bin Zhou; Andrey A Bobkov; Arthur J Olson; Peter K Vogt
Journal:  Mol Pharmacol       Date:  2009-06-04       Impact factor: 4.436

Review 4.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

5.  Expanding the proteome: disordered and alternatively folded proteins.

Authors:  H Jane Dyson
Journal:  Q Rev Biophys       Date:  2011-07-01       Impact factor: 5.318

Review 6.  Intrinsically disordered proteins are potential drug targets.

Authors:  Steven J Metallo
Journal:  Curr Opin Chem Biol       Date:  2010-07-02       Impact factor: 8.822

Review 7.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

Review 8.  Therapeutic strategies to inhibit MYC.

Authors:  Michael R McKeown; James E Bradner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

Review 9.  Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.

Authors:  Duncan E Scott; Andrew R Bayly; Chris Abell; John Skidmore
Journal:  Nat Rev Drug Discov       Date:  2016-04-11       Impact factor: 84.694

10.  A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors.

Authors:  Huabo Wang; Anand Ramakrishnan; Steven Fletcher; Edward V Prochownik
Journal:  J Biol Methods       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.